• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	101,200	03.10.24 15:33:10	-1,000	-0,98%	101,200	101,600	101,400	102,200
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	90,500	03.10.24 08:03:50	±0,000	±0,00%	90,500	92,500	90,500	90,500